Ulcerative Colitis

Ulcerative colitis is a type of inflammatory bowel disease (IBD), which causes inflammation and sores (ulcers) in the inner lining of the colon and rectum. IBD is a general term for diseases or disorders that cause inflammation in the small intestine and colon.

Ulcerative colitis is different from Crohn’s disease, another type of IBD. Crohn’s disease causes inflammation deeper within the intestinal wall. In addition, Crohn’s disease can occur in other parts of the digestive tract including the mouth, esophagus, stomach, and small intestine.

In ulcerative colitis, inflammation of the inner lining of the rectum and colon can cause ulcerations. As a result, bleeding and pus formation may occur. In addition, inflammation in the colon also causes the colon to empty frequently, causing diarrhea.

The disease may involve the entire colon—a term called pancolitis or only the rectum (ulcerative proctitis). If only the left side of the colon is affected it is called limited or distal colitis.

Who can get ulcerative colitis?

Ulcerative colitis can occur in people of any age, gender, or race. The condition appears to run in families. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), about 20 percent of people with ulcerative colitis have a family member or relative with ulcerative colitis or Crohn’s disease.

[Top of Page]

Causes

The cause of ulcerative colitis is not fully understood. Some experts believe that there may be is an abnormality in the immune system, which causes it to attack normal cells in the colon. However, more studies are being conducted to better understand the condition.

[Top of Page]

Symptoms

Symptoms of ulcerative colitis may differ from person to person. But most people with the condition experience abdominal pain and bloody diarrhea. Other signs and symptoms may include:
• anemia
• fatigue
• weight loss
• loss of appetite
• rectal bleeding
• loss of body fluids and nutrients
• skin lesions
• joint pain
• growth failure (specifically in children)
About half of the people diagnosed with the condition experience mild symptoms. In others, frequent fevers, bloody diarrhea, nausea, and severe abdominal cramping occur. Ulcerative colitis may also cause problems such as arthritis, inflammation of the eye, liver disease, and osteoporosis. Experts are not sure why these problems occur outside the colon. Scientists believe that these complications may be the result of inflammation triggered by the immune system. Some of these problems go away when the colitis is treated.

[Top of Page]

Diagnosis

Diagnosis of ulcerative colitis involves many tests and procedures. A physical exam and medical history are usually the first step.

Blood tests — This test is done to check for anemia, which could indicate bleeding in the colon or rectum, or they may uncover a high white blood cell count, which is a sign of inflammation somewhere in the body.

Stool sample analysis — This procedure can also reveal white blood cells, whose presence indicates ulcerative colitis or inflammatory disease. In addition, a stool sample allows the doctor to detect bleeding or infection in the colon or rectum caused by bacteria, a virus, or parasites.

Visual examination — A colonoscopy or sigmoidoscopy are the most accurate methods for making a diagnosis of ulcerative colitis and ruling-out other possible conditions, such as Crohn’s disease, diverticular disease, or cancer. For both tests, the doctor inserts an endoscope—a long, flexible, lighted tube connected to a computer and TV monitor—into the anus to see the inside of the colon and rectum. The doctor will be able to see any inflammation, bleeding, or ulcers on the colon wall. During the exam, the doctor may do a biopsy, which involves taking a sample of tissue from the lining of the colon to view with a microscope.

Sometimes x rays such as a barium enema or CT scans are also used to diagnose ulcerative colitis or its complications.

[Top of Page]

Treatment

Treatment for ulcerative colitis depends on the severity of the disease. Each person experiences ulcerative colitis differently, so treatment is adjusted for each individual.

Drug Therapy

The goal of drug therapy is to induce and maintain remission, and to improve the quality of life for people with ulcerative colitis. Several types of drugs are available.
  • Aminosalicylates, drugs that contain 5-aminosalicyclic acid (5-ASA), help control inflammation. Sulfasalazine is a combination of sulfapyridine and 5-ASA. The sulfapyridine component carries the anti-inflammatory 5-ASA to the intestine. However, sulfapyridine may lead to side effects such as nausea, vomiting, heartburn, diarrhea, and headache. Other 5-ASA agents, such as olsalazine, mesalamine, and balsalazide, have a different carrier, fewer side effects, and may be used by people who cannot take sulfasalazine. 5-ASAs are given orally, through an enema, or in a suppository, depending on the location of the inflammation in the colon. Most people with mild or moderate ulcerative colitis are treated with this group of drugs first. This class of drugs is also used in cases of relapse.


  • Corticosteroids such as prednisone, methylprednisone, and hydrocortisone also reduce inflammation. They may be used by people who have moderate to severe ulcerative colitis or who do not respond to 5-ASA drugs. Corticosteroids, also known as steroids, can be given orally, intravenously, through an enema, or in a suppository, depending on the location of the inflammation. These drugs can cause side effects such as weight gain, acne, facial hair, hypertension, diabetes, mood swings, bone mass loss, and an increased risk of infection. For this reason, they are not recommended for long-term use, although they are considered very effective when prescribed for short-term use.


  • Immunomodulators such as azathioprine and 6-mercapto-purine (6-MP) reduce inflammation by affecting the immune system. These drugs are used for patients who have not responded to 5-ASAs or corticosteroids or who are dependent on corticosteroids. Immunomodulators are administered orally, however, they are slow-acting and it may take up to 6 months before the full benefit. Patients taking these drugs are monitored for complications including pancreatitis, hepatitis, a reduced white blood cell count, and an increased risk of infection. Cyclosporine A may be used with 6-MP or azathioprine to treat active, severe ulcerative colitis in people who do not respond to intravenous corticosteroids.


Other drugs may be given to relax the patient or to relieve pain, diarrhea, or infection.

Some people have remissions—periods when the symptoms go away—that last for months or even years. However, most patients’ symptoms eventually return.

[Top of Page]

Hospitalization

Occasionally, symptoms are severe enough that a person must be hospitalized. For example, a person may have severe bleeding or severe diarrhea that causes dehydration. In such cases the doctor will try to stop diarrhea and loss of blood, fluids, and mineral salts. The patient may need a special diet, feeding through a vein, medications, or sometimes surgery.

[Top of Page]

Surgery

About 25 to 40 percent of ulcerative colitis patients must eventually have their colons removed because of massive bleeding, severe illness, rupture of the colon, or risk of cancer. Sometimes the doctor will recommend removing the colon if medical treatment fails or if the side effects of corticosteroids or other drugs threaten the patient’s health.

Surgery to remove the colon and rectum, known as proctocolectomy, is followed by one of the following:
  • Ileostomy, in which the surgeon creates a small opening in the abdomen, called a stoma, and attaches the end of the small intestine, called the ileum, to it. Waste will travel through the small intestine and exit the body through the stoma. The stoma is about the size of a quarter and is usually located in the lower right part of the abdomen near the beltline. A pouch is worn over the opening to collect waste, and the patient empties the pouch as needed.


  • Ileoanal anastomosis, or pull-through operation, which allows the patient to have normal bowel movements because it preserves part of the anus. In this operation, the surgeon removes the colon and the inside of the rectum, leaving the outer muscles of the rectum. The surgeon then attaches the ileum to the inside of the rectum and the anus, creating a pouch. Waste is stored in the pouch and passes through the anus in the usual manner. Bowel movements may be more frequent and watery than before the procedure. Inflammation of the pouch (pouchitis) is a possible complication.
Not every operation is appropriate for every person. Which surgery to have depends on the severity of the disease and the patient’s needs, expectations, and lifestyle. People faced with this decision should get as much information as possible by talking to their doctors, to nurses who work with colon surgery patients (enterostomal therapists), and to other colon surgery patients. Patient advocacy organizations can direct people to support groups and other information resources.

Source: Adapted from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (February 2006). NIH Publication No. 06–1597. Retrieved: March 29, 2009.

[Top of Page]

Collagenous Colitis and Lymphocytic Colitis

What are collagenous colitis and lymphocytic colitis?

Inflammatory bowel disease, or IBD, is the general name for diseases or disorders that cause inflammation in the intestines, most often referring to Crohn’s disease and ulcerative colitis. Two other types of bowel inflammation affecting the colon are collagenous colitis and lymphocytic colitis. The colon is a tube that runs from the first part of the large intestine or bowel to the rectum. Stool moves through this tube to be eliminated.

These two conditions, collagenous and lymphocytic colitis, are not related to Crohn’s disease or ulcerative colitis, which are more severe forms of IBD.

Collagenous colitis and lymphocytic colitis are also known as microscopic colitis. Microscopic colitis means that there is no visible sign of inflammation or swelling on the inner surface of the colon when viewed through colonoscopy or flexible sigmoidoscopy. These two tests let a doctor view the inside of your large intestine. Because the inflammation is not easily viewed, a test called biopsy is necessary to make a diagnosis. In this test, a small piece of tissue is removed from the lining of the intestine during a colonoscopy or flexible sigmoidoscopy. The tissue sample is then studied under a microscope.

Who gets collagenous colitis and lymphocytic colitis?

Collagenous colitis is most often diagnosed in people between 60 and 80 years of age. However, some cases have been reported in adults younger than 45 years and in children. Collagenous colitis is diagnosed more often in women than men.

People with lymphocytic colitis are also generally diagnosed between 60 and 80 years of age. Both men and women are equally affected.

Symptoms of Collagenous Colitis and Lymphocytic Colitis

The symptoms of collagenous colitis and lymphocytic colitis are the same. Symptoms may include:
• Chronic (long-term), watery, non-bloody diarrhea
• Abdominal pain or cramping
People with collagenous colitis and lymphocytic colitis may suffer from ongoing diarrhea while others have times when they are symptom free.

What causes collagenous colitis and lymphocytic colitis?

The cause of collagenous colitis or lymphocytic colitis is not fully understood. Experts believe that bacteria and their toxins, or a virus may be responsible for causing the inflammation and damage to the colon. While other scientists think that collagenous colitis and lymphocytic colitis may be because of an autoimmune response, which means that the body's immune system attacks healthy cells for no known reason.

How are collagenous colitis and lymphocytic colitis diagnosed?

Some scientists think that collagenous colitis and lymphocytic colitis are the same disease in different stages. The only way to determine which form of colitis a person has is by performing a biopsy.

A diagnosis of collagenous colitis or lymphocytic colitis is made after tissue samples taken during a colonoscopy or flexible sigmoidoscopy are examined with a microscope.

Collagenous colitis is characterized by a larger-than-normal band of protein called collagen inside the lining of the colon. The thickness of the band varies; so several tissue samples from different areas of the colon may need to be examined.
With lymphocytic colitis, tissue samples show an increase of white blood cells, known as lymphocytes, between the cells that line the colon. The collagen is not affected.

How are collagenous colitis and lymphocytic colitis treated?

Treatment for collagenous colitis and lymphocytic colitis varies depending on the symptoms and severity of the case. The diseases have been known to resolve on their own, although most people suffer from ongoing or occasional diarrhea.

Lifestyle changes are usually tried first. Recommended changes include reducing the amount of fat in the diet, eliminating foods that contain caffeine and lactose, and avoiding over-the-counter pain relievers such as ibuprofen or aspirin.

If lifestyle changes alone are not enough, medications can be used to help control symptoms.
• Treatment usually starts with prescription anti-inflammatory medications, such as mesalamine (Rowasa or Canasa) and sulfasalazine (Azulfidine), in order to reduce swelling.

• Steroids, including budesonide (Entocort) and prednisone are also used to reduce inflammation. Steroids are usually only used to control a sudden attack of diarrhea.
Long-term use of steroids is avoided because of side effects such as bone loss and high blood pressure.

• Anti-diarrheal medications such as bismuth subsalicylate (Pepto Bismol), diphenoxylate atropine (Lomotil), and loperamide (Imodium) offer short-term relief.

• Immunosuppressive agents such as azathioprine (Imuran) reduce the inflammation but are rarely needed.
For extreme cases of collagenous colitis and lymphocytic colitis that have not responded to medication, surgery to remove all or part of the colon may be necessary. However, surgery is rarely recommended.

Collagenous colitis and lymphocytic colitis do not increase a person’s risk of getting colon cancer.


www.dsdisorders.com does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this document are used only because they are considered necessary in the context of the information provided. If a product is not mentioned, the omission does not mean or imply that the product is unsatisfactory.


Source: Adapted from The National Diabetes and Digestive and Kidney Diseases (NIDDK). NIDDK is part of the National Institutes of Health. NIH Publication No. 06–5036, January 2006


[Top of Page]

National Institutes of Health (NIH) News Releases